New funding supports LMU research on pediatric inflammatory bowel disease
The non-profit Boehringer Ingelheim Stiftung supports LMU clinician-scientist Daniel Kotlarz through its Rise up! program. Daniel Kotlarz, Heisenberg…
A single blood test could offer a glimpse of disease risk years in advance
A single blood draw may reveal which cell types are aging fastest, offering a new window into disease…
Polydatin reduces ulcerative colitis by regulating intestinal immune cells
Ulcerative colitis (UC) is a chronic inflammatory bowel disease in which recurrent intestinal inflammation can be difficult to…
Molecular mapping reveals hidden cellular programs in heart transplant rejection
A new study that explores gene expression during heart transplant rejection marks a step forward for precision medicine…
Emerging non-endocytic transmembrane delivery strategies for precision medicine
Conventional endocytosis-mediated delivery is limited by poor endosomal escape efficiency, making intracellular delivery of therapeutic biomacromolecules a long-standing…
New tumor organoids strengthen precision oncology research
Significant advances have been made in the development of patient-derived tumor “organoids” for preclinical research, in two new…
Women with Parkinson’s Have More Amyloid Plaques than Men
Credit: selvanegra/Getty Images A study led by the Mayo Clinic Arizona shows women with Parkinson’s disease have greater…
Scientists uncover new molecular mechanism driving gastrointestinal stromal tumors
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the digestive tract, with KIT mutations driving…
First-in-the-world gene therapy delivers missing gene directly to infant’s brain, marking historic milestone in precision medicine
Jun 11 2026 An eight-month-old baby from Israel has become the first human ever to receive an experimental…
Digital brain twin recreates brain activity in a toddler with autism
By linking MRI anatomy with EEG dynamics, the FEDE model offers a detailed new way to study how…
Why new Alzheimer’s drugs are dividing regulators worldwide
New Alzheimer’s drugs are raising hopes, but modest benefits, ARIA safety risks, high costs, and regulatory disagreements show…
RNA therapy targets genetic cause of heart failure in the Netherlands
Using patient-derived cardiac tissue and stem cell-based models, the team of translational researchers demonstrated that targeting the genetic…